384 related articles for article (PubMed ID: 36478498)
1. Catheter-based renal denervation in Chinese patients with chronic kidney disease and uncontrolled hypertension.
Liu S; Bian R; Qian Y; Liao H; Gao X; Zhang Y; Dong W
J Clin Hypertens (Greenwich); 2023 Jan; 25(1):71-77. PubMed ID: 36478498
[TBL] [Abstract][Full Text] [Related]
2. Renal denervation preserves renal function in patients with chronic kidney disease and resistant hypertension.
Ott C; Mahfoud F; Schmid A; Toennes SW; Ewen S; Ditting T; Veelken R; Ukena C; Uder M; Böhm M; Schmieder RE
J Hypertens; 2015 Jun; 33(6):1261-6. PubMed ID: 25923731
[TBL] [Abstract][Full Text] [Related]
3. Renal denervation in patients with versus without chronic kidney disease: results from the Global SYMPLICITY Registry with follow-up data of 3 years.
Ott C; Mahfoud F; Mancia G; Narkiewicz K; Ruilope LM; Fahy M; Schlaich MP; Böhm M; Schmieder RE
Nephrol Dial Transplant; 2022 Jan; 37(2):304-310. PubMed ID: 34109413
[TBL] [Abstract][Full Text] [Related]
4. Vascular and renal hemodynamic changes after renal denervation.
Ott C; Janka R; Schmid A; Titze S; Ditting T; Sobotka PA; Veelken R; Uder M; Schmieder RE
Clin J Am Soc Nephrol; 2013 Jul; 8(7):1195-201. PubMed ID: 23559677
[TBL] [Abstract][Full Text] [Related]
5. Blood pressure response to catheter-based renal sympathetic denervation in severe resistant hypertension: data from the Greek Renal Denervation Registry.
Tsioufis C; Ziakas A; Dimitriadis K; Davlouros P; Marketou M; Kasiakogias A; Thomopoulos C; Petroglou D; Tsiachris D; Doumas M; Skalidis E; Karvounis C; Alexopoulos D; Vardas P; Kallikazaros I; Stefanadis C; Papademetriou V; Tousoulis D
Clin Res Cardiol; 2017 May; 106(5):322-330. PubMed ID: 27957627
[TBL] [Abstract][Full Text] [Related]
6. Insights on safety and efficacy of renal artery denervation for uncontrolled-resistant hypertension in a high risk population with chronic kidney disease: first Italian real-world experience.
Marin F; Fezzi S; Gambaro A; Ederle F; Castaldi G; Widmann M; Gangemi C; Ferrero V; Pesarini G; Pighi M; Ribichini FL
J Nephrol; 2021 Oct; 34(5):1445-1455. PubMed ID: 33481223
[TBL] [Abstract][Full Text] [Related]
7. Catheter-Based Renal Denervation: 9-Year Follow-Up Data on Safety and Blood Pressure Reduction in Patients With Resistant Hypertension.
Sesa-Ashton G; Nolde JM; Muente I; Carnagarin R; Lee R; Macefield VG; Dawood T; Sata Y; Lambert EA; Lambert GW; Walton A; Kiuchi MG; Esler MD; Schlaich MP
Hypertension; 2023 Apr; 80(4):811-819. PubMed ID: 36762561
[TBL] [Abstract][Full Text] [Related]
8. Sustained Decrease in Blood Pressure and Reduced Anatomical and Functional Reinnervation of Renal Nerves in Hypertensive Sheep 30 Months After Catheter-Based Renal Denervation.
Singh RR; McArdle ZM; Iudica M; Easton LK; Booth LC; May CN; Parkington HC; Lombardo P; Head GA; Lambert G; Moritz KM; Schlaich MP; Denton KM
Hypertension; 2019 Mar; 73(3):718-727. PubMed ID: 30661475
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of 3D reconstruction and basket multi-electrode renal denervation (RDN) for refractory hypertensive patients with chronic kidney disease.
Cai H; Fang Z; Wu X; Zhou W; Lin J; Peng F; Su J
J Clin Hypertens (Greenwich); 2024 Apr; 26(4):338-348. PubMed ID: 38430475
[TBL] [Abstract][Full Text] [Related]
10. Individual-patient visit-by-visit office and ambulatory blood pressure measurements over 24months in patients undergoing renal denervation for hypertension.
Lambert T; Gammer V; Nahler A; Blessberger H; Kammler J; Grund M; Kerschner K; Buchmayr G; Saleh K; Kypta A; Hönig S; Wichert-Schmitt B; Schwarz S; Sihorsch K; Reiter C; Steinwender C
Int J Cardiol; 2015 Feb; 181():96-101. PubMed ID: 25497527
[TBL] [Abstract][Full Text] [Related]
11. Renal denervation in moderate treatment-resistant hypertension.
Ott C; Mahfoud F; Schmid A; Ditting T; Sobotka PA; Veelken R; Spies A; Ukena C; Laufs U; Uder M; Böhm M; Schmieder RE
J Am Coll Cardiol; 2013 Nov; 62(20):1880-6. PubMed ID: 23850901
[TBL] [Abstract][Full Text] [Related]
12. Ten-year follow-up of very-high risk hypertensive patients undergoing renal sympathetic denervation.
Wang L; Li C; Li Z; Li Q; Liu C; Sun X; He Q; Xia DS; Xia D; Lu C
J Hypertens; 2024 May; 42(5):801-808. PubMed ID: 38164953
[TBL] [Abstract][Full Text] [Related]
13. Effects of catheter-based renal denervation on cardiac sympathetic activity and innervation in patients with resistant hypertension.
Donazzan L; Mahfoud F; Ewen S; Ukena C; Cremers B; Kirsch CM; Hellwig D; Eweiwi T; Ezziddin S; Esler M; Böhm M
Clin Res Cardiol; 2016 Apr; 105(4):364-71. PubMed ID: 26493305
[TBL] [Abstract][Full Text] [Related]
14. Blood pressure reduction after renal denervation in patients with or without chronic kidney disease.
Günes-Altan M; Schmid A; Ott C; Bosch A; Pietschner R; Schiffer M; Uder M; Schmieder RE; Kannenkeril D
Clin Kidney J; 2024 Jan; 17(1):sfad237. PubMed ID: 38186882
[TBL] [Abstract][Full Text] [Related]
15. Effect of renal denervation on kidney function in patients with chronic kidney disease.
Hering D; Marusic P; Duval J; Sata Y; Head GA; Denton KM; Burrows S; Walton AS; Esler MD; Schlaich MP
Int J Cardiol; 2017 Apr; 232():93-97. PubMed ID: 28089459
[TBL] [Abstract][Full Text] [Related]
16. The randomised Oslo study of renal denervation
Bergland OU; Søraas CL; Larstorp ACK; Halvorsen LV; Hjørnholm U; Hoffman P; Høieggen A; Fadl Elmula FEM
Blood Press; 2021 Feb; 30(1):41-50. PubMed ID: 33030064
[TBL] [Abstract][Full Text] [Related]
17. Alcohol-mediated renal denervation in patients with hypertension in the absence of antihypertensive medications.
Pathak A; Rudolph UM; Saxena M; Zeller T; Müller-Ehmsen J; Lipsic E; Schmieder RE; Sievert H; Halbach M; Sharif F; Parise H; Fischell TA; Weber MA; Kandzari DE; Mahfoud F
EuroIntervention; 2023 Sep; 19(7):602-611. PubMed ID: 37427416
[TBL] [Abstract][Full Text] [Related]
18. Adjusted drug treatment is superior to renal sympathetic denervation in patients with true treatment-resistant hypertension.
Fadl Elmula FE; Hoffmann P; Larstorp AC; Fossum E; Brekke M; Kjeldsen SE; Gjønnæss E; Hjørnholm U; Kjaer VN; Rostrup M; Os I; Stenehjem A; Høieggen A
Hypertension; 2014 May; 63(5):991-9. PubMed ID: 24591332
[TBL] [Abstract][Full Text] [Related]
19. The effect of catheter-based sham renal denervation in hypertension: systematic review and meta-analysis.
Fernandes A; David C; Pinto FJ; Costa J; Ferreira JJ; Caldeira D
BMC Cardiovasc Disord; 2023 May; 23(1):249. PubMed ID: 37173636
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of sympathetic mapping and ablation of renal nerves for the treatment of hypertension (SMART): 6-month follow-up of a randomised, controlled trial.
Wang J; Yin Y; Lu C; Lu Z; Hu J; Wang Y; Ge J; Jiang H; Yao C; Yan X; Ma W; Qi X; Dang Y; Chen S; Zhu J; Wang D; Ding C; Wang W; Liu J; Wang Y; Li H; Pan Z; Cui K; Li C; Liang X; Chen W; Sobotka PA; Zhang J; Esler M; Sun N; Chen M; Huo Y
EClinicalMedicine; 2024 Jun; 72():102626. PubMed ID: 38756107
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
